mechanistic
Analysis v1
Strong Support
Liraglutide doesn't directly lower proinsulin in people with obesity — its benefits for the pancreas seem to come mostly from weight loss, not the drug itself.
62
0
Evidence from Studies
Supporting (1)
62
Community contributions welcome
62
Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
Randomized Controlled Trial
Human
2025 Jul 18The study shows that liraglutide lowers proinsulin mainly by helping people lose weight, not by directly changing how the body processes insulin.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.